Articles dans des revues avec comité de lecture (10)
  1. 1. Sobhy, H., De Rovere, M., Ait-Ammar, A., Kashif, M., Wallet, C., Daouad, F., Loustau, T., Van Lint, C., Schwartz, C., & Rohr, O. (2024). BCL11b interacts with RNA and proteins involved in RNA processing and developmental diseases. Biochimica et Biophysica Acta. Gene Regulatory Mechanisms, 1867(4), 195065. doi:10.1016/j.bbagrm.2024.195065
  2. 2. Verdikt, R., Bendoumou, M., Bouchat, S., Nestola, L., Pasternak, A. O., Darcis, G., Avettand-Fenoel, V., Vanhulle, C., Ait-Ammar, A., Santangelo, M., Plant, E., Douce, V. L., Delacourt, N., Cicilionyte, A., Necsoi, C., Corazza, F., Passaes, C. P. B., Schwartz, C., Bizet, M., Fuks, F., Sáez-Cirión, A., Rouzioux, C., De Wit, S., Berkhout, B., Gautier, V., Rohr, O., & Van Lint, C. (2022). Novel role of UHRF1 in the epigenetic repression of the latent HIV-1. EBioMedicine, 79, 103985. doi:10.1016/j.ebiom.2022.103985
  3. 3. Bellefroid, M., Rodari, A., Galais, M., Krijger, P., Tjalsma, S., Nestola, L., Plant, E., Vos, E., Cristinelli, S. S., Van Driessche, B., Vanhulle, C., Ait-Ammar, A., Burny, A., Ciuffi, A., De Laat, W., & Van Lint, C. (2022). Role of the cellular factor CTCF in the regulation of bovine leukemia virus latency and three-dimensional chromatin organization. Nucleic acids research, 50(6), 3190-3202. doi:10.1093/nar/gkac107
  4. 4. Ait-Ammar, A., Bellefroid, M., Daouad, F., Martinelli, V., Van Assche, J., Wallet, C., Rodari, A., De Rovere, M., Fahrenkrog, B., Schwartz, C., Van Lint, C., Gautier, V., & Rohr, O. (2021). Inhibition of HIV-1 gene transcription by KAP1 in myeloid lineage (C. Van Lint, V. Gautier and O. Rohr are co-last authors, equal contribution). Scientific reports, 11(1), 2692. doi:10.1038/s41598-021-82164-w
  5. 5. Ait-Ammar, A., Kula, A., Darcis, G., Verdikt, R., De Wit, S., Gautier, V., Mallon, P., Marcello, A., Rohr, O., & Van Lint, C. (2020). Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs. Frontiers in microbiology, 10, 3060. doi:10.3389/fmicb.2019.03060
  6. 6. Lange, U. C., Verdikt, R., Ait-Ammar, A., & Van Lint, C. (2020). Epigenetic crosstalk in chronic infection with HIV-1. Seminars in Immunopathology. doi:10.1007/s00281-020-00783-3
  7. 7. Forouzanfar, F., Ali, S., Wallet, C., De Rovere, M., Ducloy, C., El Mekdad, H., El Maassarani, M., Ait-Ammar, A., Van Assche, J., Boutant, E., Daouad, F., Margottin-Goguet, F., Moog, C., Van Lint, C., Schwartz, C., & Rohr, O. (2019). HIV-1 Vpr mediates the depletion of the cellular repressor CTIP2 to counteract viral gene silencing (C. Van Lint, O. Rohr and C. Schwartz are co-corresponding authors). Scientific reports, 9(1), 13154. doi:10.1038/s41598-019-48689-x
  8. 8. Verdikt, R., Darcis, G., Ait-Ammar, A., & Van Lint, C. (2019). Applications of CRISPR/Cas9 tools in deciphering the mechanisms of HIV-1 persistence. Current opinion in virology, 38, 63-69. doi:10.1016/j.coviro.2019.07.004
  9. 9. Le Douce, V., Forouzanfard, F., Eilebrecht, S., Van Driessche, B., Ait-Ammar, A., Verdikt, R., Kurashige, Y., Marban, C., Gautier, V., Candolfi, E., Benecke, A., Van Lint, C., Rohr, O., & Schwartz, C. (2016). HIC1 controls cellular- and HIV-1- gene transcription via interactions with CTIP2 and HMGA1 (C. Van Lint, O. Rohr and C. Schwartz are co-last authors). Scientific Reports, 6, 34920. doi:10.1038/srep34920
  10. 10. Darcis, G., Kula, A., Bouchat, S., Fujinaga, K., Corazza, F., Ait-Ammar, A., Delacourt, N., Melard, A., Kabeya, K., Vanhulle, C., Van Driessche, B., Gatot, J.-S., Cherrier, T., Pianowski, L. F., Gama, L., Schwartz, C., Vila, J., Burny, A., Clumeck, N., Moutschen, M., De Wit, S., Peterlin, M., Rouzioux, C., Rohr, O., & Van Lint, C. (2015). An In-Depth Comparison of Latency-Reversing Agent Combinations in Various in vitro and ex vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression (O. Rohr and C. Van Lint are co-last authors). PLoS pathogens, 11(7), e1005063. doi:10.1371/journal.ppat.1005063
    11.   Communications publiées lors de congrès ou colloques nationaux et internationaux (1)
  11. 1. Forouzanfard, F., Ali, S., Le Douce, V., El Maasarrani, M., Ait-Ammar, A., Janossy, A., Candolfi, E., Margotin-Goguet, F., Van Lint, C., Schwartz, C., & Rohr, O. (2015). Viral counteractions against CTIP2 in HIV-1 permissive cells. 7th international workshop: HIV Persistence during Therapy
    12.   Participations à des congrès et colloques internationaux (18)
  12. 1. Bendoumou, M., Nestola, L., Dutilleul, A., & Ait-Ammar, A. (2024). Identification of a new role for the E3-ubiquitin ligase activity of UHRF1 promoting HIV-1 transcriptional silencing. Poster présenté à la conférence 1th International Workshop on HIV Persistence during Therapy (December 10-13, 2024: Fort Lauderdale, Miami, USA).
    13. << Précédent 1 2 3 Suivant >>